Literature DB >> 8879475

Serum cholesterol and treatment-resistance in schizophrenia.

P F Boston1, S M Dursun, R Zafar, M A Reveley.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1996        PMID： 8879475     DOI： 10.1016/0006-3223(96)00102-3

Source DB:  PubMed          Journal:  Biol Psychiatry        ISSN： 0006-3223            Impact factor:   13.382


× No keyword cloud information.
  3 in total

1.  The effects of clozapine on levels of total cholesterol and related lipids in serum of patients with schizophrenia: a prospective study.

Authors:  S M Dursun; A Szemis; H Andrews; M A Reveley
Journal:  J Psychiatry Neurosci       Date:  1999-11       Impact factor: 6.186

Review 2.  The neurobiology of apolipoproteins in psychiatric disorders.

Authors:  J Gregor Sutcliffe; Elizabeth A Thomas
Journal:  Mol Neurobiol       Date:  2002 Oct-Dec       Impact factor: 5.590

3.  Changes in serum lipids, independent of weight, are associated with changes in symptoms during long-term clozapine treatment.

Authors:  Ric M Procyshyn; Kishor M Wasan; Allen E Thornton; Alasdair M Barr; Eric Y H Chen; Edith Pomarol-Clotet; Emmanuel Stip; Richard Williams; G William Macewan; C Laird Birmingham; William G Honer
Journal:  J Psychiatry Neurosci       Date:  2007-09       Impact factor: 6.186
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.